RO127624A2 - Anti-acne product - Google Patents
Anti-acne product Download PDFInfo
- Publication number
- RO127624A2 RO127624A2 ROA201001261A RO201001261A RO127624A2 RO 127624 A2 RO127624 A2 RO 127624A2 RO A201001261 A ROA201001261 A RO A201001261A RO 201001261 A RO201001261 A RO 201001261A RO 127624 A2 RO127624 A2 RO 127624A2
- Authority
- RO
- Romania
- Prior art keywords
- parts
- product
- bark
- rosacea
- expressed
- Prior art date
Links
- 230000003255 anti-acne Effects 0.000 title description 2
- 241000196324 Embryophyta Species 0.000 claims abstract description 11
- 235000014134 echinacea Nutrition 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 7
- 240000002234 Allium sativum Species 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 240000007049 Juglans regia Species 0.000 claims abstract description 7
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 7
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 7
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 7
- 206010000496 acne Diseases 0.000 claims abstract description 7
- 235000004611 garlic Nutrition 0.000 claims abstract description 7
- 230000000366 juvenile effect Effects 0.000 claims abstract description 7
- 239000011347 resin Substances 0.000 claims abstract description 7
- 229920005989 resin Polymers 0.000 claims abstract description 7
- 201000004700 rosacea Diseases 0.000 claims abstract description 7
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 6
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 6
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 6
- 241001303601 Rosacea Species 0.000 claims abstract description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 244000075850 Avena orientalis Species 0.000 claims abstract description 4
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 4
- 240000004530 Echinacea purpurea Species 0.000 claims abstract description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 4
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 4
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 4
- 240000005592 Veronica officinalis Species 0.000 claims abstract description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 4
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 4
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 4
- 235000020234 walnut Nutrition 0.000 claims abstract description 4
- 235000011303 Brassica alboglabra Nutrition 0.000 claims abstract description 3
- 235000011302 Brassica oleracea Nutrition 0.000 claims abstract description 3
- 240000009089 Quercus robur Species 0.000 claims abstract description 3
- 235000011471 Quercus robur Nutrition 0.000 claims abstract description 3
- 244000272459 Silybum marianum Species 0.000 claims abstract description 3
- 235000010465 Veronica officinalis Nutrition 0.000 claims abstract description 3
- 239000001102 lavandula vera Substances 0.000 claims abstract description 3
- 235000018219 lavender Nutrition 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 14
- 230000006870 function Effects 0.000 claims description 6
- 210000001541 thymus gland Anatomy 0.000 claims description 5
- 230000000259 anti-tumor effect Effects 0.000 claims description 4
- 210000003635 pituitary gland Anatomy 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 206010062767 Hypophysitis Diseases 0.000 claims description 3
- 230000003915 cell function Effects 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 239000000419 plant extract Substances 0.000 claims description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 claims description 2
- 235000017945 Matricaria Nutrition 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 239000012676 herbal extract Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 6
- 240000004371 Panax ginseng Species 0.000 abstract description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 abstract description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 abstract description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 abstract description 3
- 241000219492 Quercus Species 0.000 abstract description 3
- 244000042664 Matricaria chamomilla Species 0.000 abstract 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract 1
- 241000109365 Rosa arkansana Species 0.000 abstract 1
- 235000005066 Rosa arkansana Nutrition 0.000 abstract 1
- 240000008530 Rosa canina Species 0.000 abstract 1
- 235000000539 Rosa canina Nutrition 0.000 abstract 1
- 241000320380 Silybum Species 0.000 abstract 1
- 235000005545 Veronica americana Nutrition 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 8
- 244000133098 Echinacea angustifolia Species 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000000567 anti-anemic effect Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012263 liquid product Substances 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 108010027164 Amanitins Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000723343 Cichorium Species 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023424 Kidney infection Diseases 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 108010009711 Phalloidine Proteins 0.000 description 1
- 208000023668 Pharyngeal disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001278097 Salix alba Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010072005 Spinal pain Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 244000047670 Viola x wittrockiana Species 0.000 description 1
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- CIORWBWIBBPXCG-JZTFPUPKSA-N amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2CC(O)C[C@H]2C(=O)N[C@@H](C(C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H](C(C)CC)C(=O)NCC(=O)N[C@H]1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-JZTFPUPKSA-N 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002364 anti-haemorrhagic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 208000003770 biliary dyskinesia Diseases 0.000 description 1
- 230000010234 biliary secretion Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 bitter principles Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000033420 disorder of pharynx Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 208000010227 enterocolitis Diseases 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N palmityl palmitate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 1
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical class C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229950000628 silibinin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Prezenta invenție se referă la un produs antiacneic, dar și antihepatic și antianemic, sub formă pulverulentă, pentru stimularea funcțiilor celulare și implicit refacerea funcțiilor organismului, cu extracte din plante, cu efect asupra glandelor hipofiză și al thymusului, dar și antitumoral. antianemic, sau antihepatic, pentru orice vârstă.The present invention relates to an anti-acne but also anti-hepatic and anti-anemic product, in powder form, for stimulating cellular functions and implicitly restoring body functions, with plant extracts, with effect on the pituitary and thymus glands, but also antitumor. antianemic, or anti-hepatic, for any age.
Se cunosc alte produse cu efect antiacneic pe bază de plante: 1. Viola tricolor, Humulus lupulus, Crataes monogyna, Cichorium inthybus, Triticum aestivum, + unguent (produs extern) (122662 Bl); 2. Rhizoma calami, Herba chelidoni, (macerat), + Cortex betulae, Cortex salix alba, Cortex quercus, (decoct) + Folium Betulae, Flores calendulae, Herba milefolii, Folium salviae, (infuzie).Other herbal products with antacneic effect are known: 1. Viola tricolor, Humulus lupulus, Crataes monogyna, Cichorium inthybus, Triticum aestivum, + ointment (external product) (122662 Bl); 2. Rhizoma calami, Herba chelidoni, (macerated), + Cortex betulae, Cortex salix alba, Cortex quercus, (decoct) + Folium Betulae, Flores calendulae, Herba milefolii, Folium salviae, (infusion).
Produsele susmenționate au dezavantajele următoare: produsul 1 este un unguent ceea ce nu elimină cauza poroducerii acneei fiind un produs extern, iar produsul 2 este dificil de aplicat fiind format din 3 produse ce se ingereazăîn diferite momente ale zilei prestabilite anterior.The above products have the following disadvantages: product 1 is an ointment which does not eliminate the cause of acne poroduction being an external product, and product 2 is difficult to apply being made up of 3 products that are ingested at different times of the previous day.
Produsul pulverulent, conform invenției, elimină dezavantajele anterioare astfel: deși are în conținut mai multe plante este un singur produs care se ingerează, deci intern produce o stimulare a glandelor, dar și o remineralizare + o revitaminizare, ceea ce ajută organismul să reintre în funcție normală și să elimine orice tip de acnee, el fiind în același timp și antihepatic, antianemic, antitumoral și antiastenic, se poate aplica la orice oră din zi, fără o rigurozitate anume și de oricine.The pulverulent product, according to the invention, eliminates the above disadvantages as follows: although it contains several plants, it is a single product that is ingested, so internally it produces a stimulation of the glands, but also a remineralization + a revitaminization, which helps the body to re-function. normal and to eliminate any type of acne, being at the same time anti-hepatic, anti-anemic, anti-tumor and anti-asthenic, it can be applied at any time of the day, without any particular rigor and by anyone.
Prezentul produs are o formulă nouă și diferită față de alte produse de acest fel, existente în lume și în țară.This product has a new and different formula from other products of this kind, existing in the world and in the country.
Problema tehnică pe care o rezolvă invenția constă din elaborarea unei compoziții din plante indigene, care în combinația respectivă, conduce la un efect sinergie pentru tratarea unei manifestări de acnee rozacee sau juvenilă.The technical problem that the invention solves consists of the elaboration of a composition of indigenous plants, which in the respective combination, leads to a synergistic effect for treating a manifestation of rosacea or juvenile acne.
Această invenție lărgește gama de produse fîtoterapeutice pentru stimularea funcției glandelor hipofize și al thymusului, dar și a întregului organism, și valorifică în scop terapeutic specii de plante ce cresc numai în țara noastră.This invention broadens the range of phytotherapeutic products to stimulate the function of the pituitary glands and of the thymus, but also of the whole organism, and exploits for therapeutic purposes plant species that grow only in our country.
Produsul rezolvă mai multe probleme, astfel: datorită substanțelor active menționate în continuare, ce acționează la reglarea funcției thymusului și al hipofizei și deci al întregului organism se pot obține rezultate notabile în reactivarea funcției generale a organismului. Practic, compoziția propusă din invenție, stimulează activitatea cerebrală și cea glandulară, ducând în final la o reglare normală a funcțiilor organismului uman.The product solves several problems, as follows: thanks to the active substances mentioned below, which act to regulate the function of the thymus and pituitary gland and thus of the whole organism, remarkable results can be obtained in reactivating the general function of the organism. Basically, the composition proposed in the invention stimulates brain and glandular activity, eventually leading to a normal regulation of the functions of the human body.
Avantajele pe care le are noua formulă se bazează pe substanțe active naturale existente în plantele din formulă, cum sunt: floroglucina, rezine, acid cvercitanic, cvercină, substanțe pectice, oxalat de calciu, pectine, principii amare, cupru, mangan, crom, nichel, bariu, stronțiu, potasiu, calciu, magneziu, fosfor, sodiu, fier, sulf, zinc, seleniu, hidrați de carbon, caroten, albumină, rășini, oxid de fier, sulfat deThe advantages of the new formula are based on natural active substances existing in the plants of the formula, such as: floroglucine, resins, quercanic acid, quercin, pectic substances, calcium oxalate, pectin, bitter principles, copper, manganese, chromium, nickel , barium, strontium, potassium, calcium, magnesium, phosphorus, sodium, iron, sulfur, zinc, selenium, carbohydrate, carotene, albumin, resins, iron oxide, sulfate
OFICIUL DE STAT PENTRU INVENȚII Șl MĂRCITHE STATE OFFICE FOR INVENTIONS THE MARK
Cerere de brevet de invențiePatent application
Nr.Nr.
Data depozit »*2010-01261--Date of filing »* 2010-01261--
Ο -II- 2010 potasiu, lipide, glucide, protide, vit. Bl, B2, K, A, C, PP, A, D2, ulei volatil, linaiol, geranilol, borneol, cineol, heterozide cardiotonice, flavonozide, saponozide de natură steroidică, coline, acetilcoline și mucilagii, digitalină, acid nicotinic, zaharuri, tanin, acid citric, galic și malic.II -II- 2010 potassium, lipids, carbohydrates, proteins, vit. Bl, B2, K, A, C, PP, A, D2, volatile oil, linaiol, geranilol, borneol, cineole, cardiotonic heterozygous, flavonozide, steroid saponozide, choline, acetylcholine and mucilage, digitaline, nicotinic acid, sugars, tannin, citric acid, gallic and malic.
Alte avantaje ale noului produs sunt: nu prezintă reacții adverse, se administrează ușor, are acțiune puternică în: afecțiuni ale pielii, antihepatic, antianemic și antitumoral.Other benefits of the new product are: it has no side effects, it is easy to administer, it has strong action in: skin disorders, antihepatic, anti-anemic and anti-tumor.
Efectele terapeutice și farmacodinamice principale sunt următoarele: antihemoragic, antisudorific, stimulent tiroidian, energizant, antimigrenos, antihemoroidal, antireumatic, antibronșic, reechilibrant general, antianemic, susține echilibrul nervos, antianginos, antiastenic, anticonvulsiv, remineralizant, antihepatic, antiscorbutic, antitumoral, antianemic, calmant al sistemului nervos central, anispastic, dezinfectant, cardiotonic, crește puterea de contracție a cordului, ameliorează circulația sângelui, crește oxigenarea țesuturilor, înlătură stazele și edemele, normalizează secrețiile biliare, folosit în gingivite, leziuni anale, faringite, afecțiuni ale pielii, inflamații intestinale, arsuri. Toate aceste efecte duc în final la obținerea efectului scontat, de eliminarea acneei rozacee și a celei juvenile.The main therapeutic and pharmacodynamic effects are: anti-hemorrhagic, anti-sweating, thyroid stimulant, energizing, anti-migraine, anti-hemorrhoidal, anti-rheumatic, anti-bronchial, general rebalancing, anti-anemic, sustains nervous balance, anti-angina, antiastenic, anti-convulsive, anti-hemorphic, reminal soothing of the central nervous system, anispastic, disinfectant, cardiotonic, increases the contraction power of the heart, improves blood circulation, increases tissue oxygenation, removes stasis and edema, normalizes biliary secretions, used in gingivitis, anal lesions, pharyngeal disorders, infections intestinal burns. All of these effects eventually lead to the expected effect of eliminating rosacea and juvenile acne.
Prezenta invenție se referă la un produs sub formă pulverulentă, pentru stimularea funcțiilor celulare și implicit refacerea funcțiilor organismului, cu extracte din plante, cu efect asupra glandelor liipofiză și thymus, pentru combaterea afecțiunilor dermatologice de tip acnee rozacee și juvenilă este constituită din: 8-15 părți Rădăcina vieții (Ginseng); 9-15 părți scoarță Nuc (Juglans Regia); 9-15 părți Levănțică (Lavandula angustifolia); 7-15 părți scoarță Stejar (cortex Quercus robur); 6-10 părți semințe Armurariu (Silybum marianum); 7-18 părți Ovăz (Avena sativa); 7-13 părți Varză (Brassica oleracea); 715 părți Zmeur (Rubus idaeus); 7-16 părți Echinaceea purpurea; 7-1 1 părți Usturoi (Allium sativum); 6-10 părți Ventrilică (Veronica officinalis); 3-7 părți Măceșe (Roșa canina); 5-10 părți Mușețel (Matricaria Charmomilla); 2-4 părți Rășină de Brad; 3-8 părți Acid Ascorbic; 3-8 părți KC1; eventual 20-22 părți alcool de 7-10°, pentru plante părțile sunt exprimate în greutate, iar pentru lichide părțile sunt exprimate în volum.The present invention relates to a product in powder form, to stimulate the cellular functions and implicitly the restoration of the functions of the body, with plant extracts, with effect on the lipids and thymus glands, to combat the dermatological disorders of acne rosacea and juvenile type: 8- 15 parts The root of life (Ginseng); 9-15 parts bark Walnut (Juglans Regia); 9-15 parts Levantica (Lavandula angustifolia); 7-15 parts Bark Oak (Quercus robur cortex); 6-10 parts seeds Armurariu (Silybum marianum); 7-18 parts Ovăz (Avena sativa); 7-13 parts Cabbage (Brassica oleracea); 715 parts Raspberry (Rubus idaeus); 7-16 parts Echinacea purpurea; 7-1 1 parts Garlic (Allium sativum); 6-10 parts Ventrilica (Veronica officinalis); 3-7 parts Măceșe (Roşa canina); 5-10 parts Muşețel (Matricaria Charmomilla); 2-4 parts Brad Resin; 3-8 parts Ascorbic Acid; 3-8 parts KC1; possibly 20-22 parts alcohol of 7-10 °, for plants the parts are expressed by weight, and for liquids the parts are expressed in volume.
Se dă în continuare un exemplu de realizare a prezentei invenții ce are următoarea compoziție: 8 părți Ginseng; 9 părți scoarță Nuc; 7 părți Echinaceea; 9 părți Lavandă; 9 părți scoarță Stejar; 9 părți Zmeur; 6 părți Armurariu; 8 părți Ovăz; 9 părți Varză; 10 părți Ventrilică, 7 părți Usturoi, 5 părți Mușețel, 2 părți Rășină de conifere, 7 părți Măceșe, 8 părți Acid Ascorbic; 8 părți KC1; eventual 20 părți alcool etilic de 10°.Following is an example of embodiment of the present invention having the following composition: 8 parts Ginseng; 9 parts bark Walnut; 7 parts Echinacea; 9 parts Lavender; 9 parts oak bark; 9 parts Raspberry; 6 parts Armorario; 8 parts Oatmeal; 9 parts Cabbage; 10 parts Ventrilica, 7 parts Garlic, 5 parts Muşețel, 2 parts Conifer resin, 7 parts Măceșe, 8 parts Ascorbic acid; 8 parts KC1; possibly 20 parts 10 ° ethyl alcohol.
Se cunoaște că Rădăcina vieții (Ginseng): întărește sistemul imunitar, stimulează activitatea sexuală, normalizează tensiunea arterială și glicemia, scade colesterolul și protejează ficatul, este eficient în surmenaj, stress, oboseală cronică, neurastenii, depresii, convalescență, crește capacitatea de concentrare, crește imunitateă, păstrează integritatea vaselor de sânge și funcționarea normală a inimii, antivomitiv, tonic gastric, stimulent limfatic, împotriva vertijului, tonic energetic și stimulant al fucțiilor (X1 Ο 1 Ο - Ο 1 2 6 1 - 3 Ο -Π- 2010 cognitive, accelerează și normalizează metabolismul, regenerează vilozitățile intestinale, detoxifică organismul, stimulează regenerarea celulară, tonic, favorizează absorbția alimentelor. Compușii activi chimic, conțin un amestec complex de saponozide triterpenice cunoscute sub denumirea de ginsenozide. Cele mai importante au fost denumite codificat Rbl, Rb2, Rb3, Rc și Rd, derivați ai protopanaxadiolului, iar Re, Rf, Rgl, Rg2 și Rhl, derivați ai protopanaxatriolului. Până în prezent sunt identificate și caracterizate 30 ginsenozide.It is known that the root of life (Ginseng): strengthens the immune system, stimulates sexual activity, normalizes blood pressure and blood sugar, lowers cholesterol and protects the liver, is effective in overwork, stress, chronic fatigue, neurasthenia, depression, convalescence, increases the ability to concentrate, increases immunity, preserves the integrity of the blood vessels and normal functioning of the heart, antivomitive, gastric tonic, lymphatic stimulant, against dizziness, energetic tonic and stimulant of fusions (X1 Ο 1 Ο - Ο 1 2 6 1 - 3 Ο -Π- 2010 cognitive , accelerates and normalizes metabolism, regenerates intestinal villi, detoxifies the body, stimulates cell regeneration, tonic, promotes food absorption Chemically active compounds, contain a complex mixture of triterpenic saponozides known as ginsenosides. The most important have been called R2 coding. , Rb3, Rc and Rd, derivatives ai protopanaxadiol, and Re, Rf, Rgl, Rg2 and Rhl, derivatives of protopanaxatriol. To date, 30 ginsenosides have been identified and characterized.
Se cunoaște că flavonoidele din compoziția semințelor de Armurariu favorizează regenerarea celulelor hepatice, măresc capacitatea organismului și în special al ficatului, de a se apăra de infecții (Hepatite). Silibinina conținută de armurariu, împiedică procesul de acumulare a toxinelor în ficat, favorizează activitatea celulelor hepatice, stimulează eliminarea compușilor toxici din celulele hepatice (icter, insuficiența hepatică). Este un foarte bun stimulent al activității ficatului, împiedică fibrozarea acestuia și ajută la regenerarea sa (ciroza hepatică). Are un puternic efect de stimulare a producției de bilă, favorizează eliberarea acesteia, împiedică acumularea calculilor la nivelul vezicii biliare și diminuează stările inflamatori (diskinezie biliară, litiaza biliară). în otrăvirea cu ciuperci toxice, armurariul susține activitatea hepatică și neutralizează direct acțiunea unor substanțe toxice din ciuperci (amanitina și faloidina), în intoxicații cu metanol, cu tetraclorura de carbon, cu metale grele (plumb, mercur), sau cu medicamente care atacă ficatul. Este un tratament adjuvant foarte util pentru protejarea organelor interne și al sistemului nervos. Armurariul nu diminuează depedența de alcool, însă ajută la refacerea ficatului (greu încercat de consumul sistematic al acestei substanțe) și susține activitatea nervoasă, ajutând la recăpătarea reflexelor și a coordonării normale, reducând tremurul membrelor și alte simptome de acest gen. în Psoriazis s-au obținut rezultate remarcabile. Această plantă activează sistemul imunitar (favorizând fagocitarea celulelor maligne), neutralizează radicalii liberi, reîntinerește organismul, susține activitatea hepatică, menține capacitatea de luptă a sistemul imunitar și împiedică apariția simptomelor neurologice.It is known that the flavonoids in the composition of Armurariu seeds favor the regeneration of liver cells, increase the capacity of the body and especially of the liver, to defend itself against infections (Hepatitis). The silibinin contained in the armorarium prevents the accumulation of toxins in the liver, promotes the activity of the liver cells, stimulates the elimination of toxic compounds from the liver cells (jaundice, hepatic insufficiency). It is a very good stimulant of the activity of the liver, prevents its fibrosis and helps its regeneration (cirrhosis of the liver). It has a strong stimulating effect on the production of bile, favors its release, prevents the accumulation of gallstones and diminishes inflammatory conditions (biliary dyskinesia, biliary lithiasis). In poisoning mushrooms, the armory supports the liver activity and directly neutralizes the action of toxic fungi (amanitin and phalloidin), intoxication with methanol, carbon tetrachloride, heavy metals (lead, mercury), or with drugs that attack . It is a very useful adjuvant treatment for the protection of the internal organs and nervous system. Armouring does not diminish alcohol dependence, but it helps to restore the liver (difficult to try for systematic consumption of this substance) and supports nervous activity, helping to regain reflexes and normal coordination, reducing limb tremor and other such symptoms. Remarkable results have been obtained in Psoriasis. This plant activates the immune system (favoring phagocytosis of malignant cells), neutralizes free radicals, rejuvenates the body, sustains liver activity, maintains the immune system's fighting ability and prevents neurological symptoms.
Se cunoaște că Echinaceea purpurea este folosită pentru eliminarea infecțiilor. Ea stimulează organismul să producă mai multe globule albe, în special limfocite și o cantitate mare de interferoni (una dintre cele mai puternice substanțe anti-infecțioase naturale). Pe lângă acțiunea imunostimulatoare pe care o manifestă, echinaceea este recomandată persoanelor cu leziuni ale pielii (furuncul) și are efecte tonice, îmbunătățind abilitatea ficatului de a reduce efectele factorilor toxici din mediu. Tratamentul natural cu echinaceea nu interacționează cu alte medicamente sau suplimente. Acestă abilitate a plantei, de a preveni formarea enzimelor, este cunoscută sub numele de hialuronidază. Această enzimă distruge bariera naturală între țesuturile sănătoase și țesuturile infectate. Echinaceea ajută organismul să lupte împotriva infecțiilor prin stimularea ficatului, glandelor limfatice și a membranelor mucoaselor. Studiile au demonstrat eficiența echinaceei împotriva infecțiilor bacteriologice, virale și micologice. Echinaceea a fost folosită și în bolile de piele ca eczeme și psoriazis, întărește sistemul imunitar, accelerează vindecarea, luptă contra ϋ\’ 2 0 1 0 - 0 1 2 6 1 - 3 0 -11- 2010 bacteriilor și infecțiilor, printre care infecțiile virale sau micologice, ajută la vindecarea arsurilor, alină durerile și infectarea de la înțepăturile insectelor (incluzând cele otrăvitoare), ajută în tratarea infecțiilor sinusului, ajută în tratarea infecțiilor rinichilor, reduce gripa și simptomele ei, reduce inflamațiile. și folosită ca gargară scade durerile de gât.Echinacea purpurea is known to be used to eliminate infections. It stimulates the body to produce more white blood cells, especially lymphocytes and a large amount of interferons (one of the most potent natural anti-infectious substances). In addition to its immunostimulatory action, echinacea is recommended for people with skin lesions (boils) and has tonic effects, improving the liver's ability to reduce the effects of toxic factors in the environment. Natural treatment with echinacea does not interact with other drugs or supplements. This ability of the plant to prevent enzyme formation is known as hyaluronidase. This enzyme destroys the natural barrier between healthy and infected tissues. Echinacea helps the body fight infections by stimulating the liver, lymph glands and mucous membranes. Studies have shown the efficacy of echinacea against bacteriological, viral and mycological infections. Echinacea has also been used in skin diseases such as eczema and psoriasis, strengthens the immune system, accelerates healing, fights against iilor \ '2 0 1 0 - 0 1 2 6 1 - 3 0 -11-2010 bacteria and infections, including infections viral or mycological, it helps to heal burns, relieve pain and infection from insect bites (including poisonous), helps treat sinus infections, helps treat kidney infections, reduces flu and its symptoms, reduces inflammation. and used as a gargle, neck pain decreases.
Se cunoaște că Rășina de brad, sub formă de tinctură, se poate folosi la fel ca mugurii sau cetina. Acțiunea farmacologică este: astringentă, cicatrizantă, antibiotică, bun expectorant, calmează durerile, are efect răcoritor, revulsiv, repermeabilizant vascular, vitaminizat, etc. Rășina de brad se poate folosi în următoarele afecțiuni: abcese, afecțiuni ginecologice, amigdalite, angiocolite, angiodermite, boli de rinichi, boli de nervi, boli pulmonare, bronșite, cervicite, contuzii, colite, discopatii, dureri articulare, dureri de coloană, dureri reumatice, eczeme, enterocolite, faringite, furunculoză, gripă, guturai, hemoroizi, infecții ale pielii, infecții urinare, nevroze, nevralgii, parodontoză, paralizii, purpure, răni ale colului uterin, răni anale, răni externe, răni purulente, reumatism, tulburarea permeabilității capilare, tuse, ulcere de gambă, ulcerații cronice, vânătăi.It is known that fir resin, in the form of tincture, can be used as buds or cetin. The pharmacological action is: astringent, healing, antibiotic, good expectorant, relieves pain, has a cooling effect, revulsive, vascular re-permeabilizing, vitaminized, etc. The fir resin can be used in the following conditions: abscesses, gynecological conditions, tonsillitis, angiocolitis, angiodermitis, kidney disease, nerve disease, lung disease, bronchitis, cervicitis, contusions, colitis, discopulations, joint pain, spinal pain, pain rheumatic, eczema, enterocolitis, pharyngitis, furunculosis, influenza, gout, hemorrhoids, skin infections, urinary tract infections, neuroses, neuralgia, periodontitis, paralysis, purpura, cervical sores, anal sores, external sores, purulent sores, re capillary permeability, cough, leg ulcers, chronic ulcers, bruising.
Produsul poate fi prezentat sub formă pulverulentă sau lichidă.The product can be presented in powder or liquid form.
Mod de preparare: plantele alese se lasă la uscat, după care se fragmentează până la dimensiuni de 0.1-0.2 mm, apoi se amestecă într-un malaxor, iar materia pulverulentă de culoare verzuie, astfel obținută se capsulează, sau se ambalează în sticluțe.Method of preparation: The selected plants are left to dry, then fragment to a size of 0.1-0.2 mm, then mixed in a mixer, and the greenish-colored powdery material thus obtained is encapsulated, or packaged in bottles.
Dacă se dorește obținerea produsului lichid tip biter, plantele alese se lasă la uscat, după care se fragmentează până la dimensiuni de 0,3-0,5 mm, apoi se amestecă într-un malaxor, iar peste materia pulverulentă de culoare verzuie, se adaugă alcoolul de 30°-40°, se așteaptă 4 zile, se adăugă apa pentru obținerea celor 7°-10° alcoolice, se filtrează și se ambalează.If it is desired to obtain the liquid product type biter, the selected plants are left to dry, then they are fragmented to dimensions of 0,3-0,5 mm, then mixed in a mixer, and over the powdered green matter, add 30 ° -40 ° alcohol, wait 4 days, add water to obtain the 7 ° -10 ° alcohol, filter and pack.
Testele au fost aplicate pe un număr de 10 persoane ce s-au oferit pentru testări, acestea suferind de diverse tipuri de acenee rozacee sau juvenilă. Subiecții au fost rugați să nu modifice comportamentul zilnic, pentru a se observa acțiunea strictă a produsului.The tests were applied to a number of 10 people who offered for testing, suffering from various types of rosacea or juvenile acne. Subjects were asked not to change their daily behavior in order to observe the strict action of the product.
La testările biochimice realizate nu s-au înregistrat efecte secundare.There were no side effects to the biochemical tests performed.
(^2010-01261-3 Ο -11- 2010(^ 2010-01261-3 Ο -11- 2010
Controlul materiilor prime se face conform normelor de calitate din Farmacopeea Europeană.The control of raw materials is done according to the quality norms of the European Pharmacopoeia.
Doza apreciată ca fiind eficientă, conform testărilor preliminare, în cazul produsului pulverulent, a fost de 4-8 capsule pe zi, luate la intervale egale de timp. Administrarea s-a făcut cu 15-20 de minute înainte mesele de prânz și seara, dar efectele mai puternice au fost înregistrate când administrarea a fost făcută la 10-15 minute după mesele principale.The dose considered to be effective, according to preliminary tests, in the case of the powdered product, was 4-8 capsules per day, taken at equal intervals. The administration was done 15-20 minutes before lunch and evening, but the stronger effects were recorded when the administration was done 10-15 minutes after the main meals.
Pentru produsul lichid s-a încercat administrarea și înainte și după mese, acțiunea mai puternică observându-se atunci când produsul a fost ingerat după mese. Doza apreciată ca fiind eficientă, conform testărilor preliminare, în cazul produsului lichid este de 60-80ml/zi, în 2-4 doze.For the liquid product the administration was tried both before and after meals, the stronger action being observed when the product was ingested after meals. The dose considered to be effective, according to preliminary tests, in the case of the liquid product is 60-80ml / day, in 2-4 doses.
Produsul pulverulent ambalat în sticluțe se poate folosi la obținerea unei infuzii care este necesar să fie potențat de o linguriță de miere.The powdered product packaged in bottles can be used to obtain an infusion that needs to be enhanced by a teaspoon of honey.
Produsul se asociază și cu un meniu stabilit în funcție și de alte diagnostice ale pacientului.The product is also associated with a menu established according to other diagnoses of the patient.
Produsul poate fi ingerat la orice oră din zi, fără o anumită rigurozitate, importat fiind ca administrarea să se repete de mai multe ori pe zi, cu recomandarea ca administrarea să fie de minim 2 ori pe zi.The product can be ingested at any time of the day, without a certain rigor, it being imported that the administration be repeated several times a day, with the recommendation that the administration be at least 2 times a day.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA201001261A RO127624B1 (en) | 2010-11-30 | 2010-11-30 | Anti-acne product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA201001261A RO127624B1 (en) | 2010-11-30 | 2010-11-30 | Anti-acne product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO127624A2 true RO127624A2 (en) | 2012-07-30 |
| RO127624B1 RO127624B1 (en) | 2013-08-30 |
Family
ID=46575975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ROA201001261A RO127624B1 (en) | 2010-11-30 | 2010-11-30 | Anti-acne product |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO127624B1 (en) |
-
2010
- 2010-11-30 RO ROA201001261A patent/RO127624B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO127624B1 (en) | 2013-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Green blood therapy of wheat grass-Nature’s finest medicine’-A literature review | |
| Thorat et al. | Brahmi-The memory booster medicinal herb | |
| CN104435356B (en) | The herbal composite of anti-chicken heat shock | |
| RO127624A2 (en) | Anti-acne product | |
| EP1231928B1 (en) | Phytotherapeutic composition | |
| Szyszkowska et al. | The use of medicinal plants in dental treatment | |
| CN110652552A (en) | Wound healing formula and preparation method | |
| Srinivasan et al. | Biochemical and molecular mechanisms for medicinal properties of honey | |
| RU2452242C1 (en) | Biologically active food additive production method | |
| CN100387291C (en) | Medicine for treating pulmonary tuberculosis | |
| Simons | The healing power of plants: medical plants from Abuta and Acerola to Yohimbe and Yucca: a practical selection | |
| RO127625A2 (en) | Antiarthrotic product | |
| Birajdar et al. | Alternative and complementary treatment modalities in oral lesions | |
| US12383597B1 (en) | Medical treatment composition, method of preparation and treatment method | |
| CN103525640A (en) | Energy-keeping yang-tonifying wine | |
| Downs et al. | Design of a Novel Bioflavonoid and Phytonutrient Enriched Formulation in Boosting Immune Competence and Sports Performance: A product Development Investigation | |
| RO127811A2 (en) | Antiallergic product | |
| CN107744551A (en) | A kind of anaesthetic and its manufacture method for treating gastrointestinal disease | |
| RO127627A2 (en) | Product for eliminating the effects of menopause installation | |
| RU2315610C1 (en) | Curative-prophylactic remedy for cattle youngsters and method for preventing and treating viral gastrointestinal diseases in calves and its application | |
| RO127268A2 (en) | Antistress product | |
| CN104474150B (en) | A kind of pharmaceutical composition and preparation method with oxygen lack resistant function | |
| CN105309920A (en) | Health product for improving body immunity, and making method thereof | |
| CN117205245A (en) | Traditional Chinese medicine water extract and preparation method and application thereof | |
| RO127810A2 (en) | Antibronchitis product |